Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8814820 Ocular implant with therapeutic agent and methods thereof

Patent 8814820 was granted and assigned to Glaukos Corporation on August, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Glaukos Corporation

Current Assignee

Glaukos Corporation

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88148200

Patent Inventor Names

Morteza Gharib0

Olav B Bergheim0

Date of Patent

August 26, 2014

Patent Application Number

136237670

Date Filed

September 20, 2012

Patent Citations Received

‌

US Patent 11992551 Implants with controlled drug delivery features and methods of using same

‌

US Patent 11744458 Gonioscopes

‌

US Patent 11925578 Drug delivery implants with bi-directional delivery capacity

‌

US Patent 11944573 System and method for delivering multiple ocular implants

Patent Primary Examiner

‌

Adam Marcetich

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8814820 Ocular implant with therapeutic agent and methods thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API